- Tytuł:
- The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)
- Autorzy:
- Źródło:
- Journal of Cancer Research and Clinical Oncology. 149(8):4141-4148
Czasopismo naukowe